COVID-19 and cancer chemotherapy
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C00-D49- Neoplasms
- Registration Number
- CTRI/2020/05/025217
- Lead Sponsor
- Dr Bhawna Sirohi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All adult (more than 18 years of age) cancer patients currently on active chemotherapy treatment at Max Institute of Cancer Care
Exclusion Criteria
Patients not able to give consent
Patient less than 18 years age on the day of enrollment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To describe change in cancer treatment patterns as a result of the pandemicTimepoint: 6 months from start of enrollment
- Secondary Outcome Measures
Name Time Method To assess impact on short-term morbidity <br/ ><br>Assess impact on patient experience (questionnaire based)Timepoint: End of study